# Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers

> **NCT04747054** · PHASE3 · RECRUITING · sponsor: **UNICANCER** · enrollment: 102 (estimated)

## Conditions studied

- Squamous Cell Carcinoma of Head and Neck

## Interventions

- **DRUG:** Pembrolizumab
- **RADIATION:** Loco-regional radiotherapy
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT04747054
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-01
- **Primary completion:** 2025-10-01
- **Final completion:** 2029-10-01
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2024-10-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04747054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04747054, "Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04747054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*